Clinical Trial Update: Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor [Phase 2]

View source ↗

Summary

A Phase 2, double-blind, placebo-controlled study evaluating multiple-dose sodium oxybate in essential tremor has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2012-01-23